Similar articles

• Use of immunomodulary agents is difficult in treating autoimmune hepatitis patients.

  Gordon FD, Simpson M. Gordon FD, et al. J Clin Gastroenterol. 2004 Oct;38(9):729-30. doi: 10.1097/01.mcg.0000139177.33502.47. J Clin Gastroenterol. 2004. PMID: 15365394 No abstract available.
• [Treatment of autoimmune hepatitis].

  Múzes G. Múzes G. Orv Hetil. 2003 Jul 27;144(30):1497-8. Orv Hetil. 2003. PMID: 14569681 Review. Hungarian. No abstract available.
• Immunosuppressive therapy in children.

  Prasad R, Singh UK, Mittal R, Mishra OP. Prasad R, et al. J Indian Med Assoc. 2011 Feb;109(2):101-2, 104-7. J Indian Med Assoc. 2011. PMID: 21888174 Review.
• Efficacy of conventional immunosuppressive drugs in IBD.

  Caprilli R, Angelucci E, Cocco A, Viscido A, Zippi M. Caprilli R, et al. Dig Liver Dis. 2004 Nov;36(11):766-80. doi: 10.1016/j.dld.2004.06.014. Dig Liver Dis. 2004. PMID: 15571009 Review.
• Evolving new therapies of autoimmune hepatitis.

  Vierling JM, Flores PA. Vierling JM, et al. Clin Liver Dis. 2002 Aug;6(3):825-50, ix. doi: 10.1016/s1089-3261(02)00029-6. Clin Liver Dis. 2002. PMID: 12362583 Review.